Join to View Full Profile
2330 Shawnee Mission PkwySte 210Westwood, KS 66205
Phone+1 913-588-6030
Fax+1 913-588-4085
Dr. Shune is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2010 - 2013
University of MinnesotaResidency, Internal Medicine, 2007 - 2010
Istanbul University FomClass of 2004
Certifications & Licensure
MO State Medical License 2021 - 2027
KS State Medical License 2014 - 2026
MN State Medical License 2007 - 2013
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
Clinical Trials
- Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency Start of enrollment: 2021 Nov 02
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.Andrew J Portuguese, James A Davis, Shahzad Raza, Omar Castaneda Puglianini, Ciara Freeman
Blood Cancer Journal. 2026-03-27 - Predictors of 30-day readmissions post-CAR-T in patients with relapsed/refractory multiple myeloma using the United States nationwide readmission database.Raj Shah, Nikhil Vojjala, Tiewei Cheng, Charmi Bhanushali, Sanjana Mullangi
Annals of Hematology. 2026-03-23 - The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma.Matthew J Rees, Raffaella Cassano Cassano, Melinda Tan, Eli Zolotov, Surbhi Sidana
American Journal of Hematology. 2026-03-20
Press Mentions
Community Oncology Practices Can Overcome Hurdles in Providing Bispecifics for Multiple MyelomaApril 28th, 2025
“Icing and the Cherry on Top”: Cilta-Cel Improves Quality of Life in Multiple MyelomaMarch 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










